[1]
“Oral Nifedipine Versus Intravenous Labetalol in the Management of Severe Pregnancy Induced Hypertension: A Randomized Control Trial”, Chatt Maa Shi Hosp Med Coll J, vol. 20, no. 1, pp. 55–61, May 2021, doi: 10.3329/cmoshmcj.v20i1.53589.